Overall, a plethora of signalling cascades have been reported to be activated downstream of ASIC activation in different carcinomas – increase in ROS, activation of RhoA, NFAT, PI3K, or AKT—all due to an increase in [Ca2+]i triggered by ASICs. Here, RHOA is linked to carcinoma.